• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Kawase Reiko  川瀬 玲子

ORCIDConnect your ORCID iD *help
Researcher Number 50746740
Affiliation (based on the past Project Information) *help 2017 – 2018: 三重大学, 医学部, 技術補佐員
2016: 三重大学, 医学系研究科, 技術補佐員
2015: 三重大学, 医学(系)研究科(研究院), 助教
2015: 三重大学, 大学院医学系研究科, 助教
Review Section/Research Field
Except Principal Investigator
General pharmacology
Keywords
Except Principal Investigator
ゼブラフィッシュ / 心血管・血液 / オミックス解析 / 公共データベース / ユビキチン・プロテアソーム系 / 酸化ストレス / ゲノム編集 / データベース / オミクス解析 / トランスクリプトーム … More / 肥大型心筋症 / がん幹細胞選択性 / 蛍光試薬 / 免疫不全マウス / ヒトがん幹細胞治療薬 / 悪性腫瘍治療抵抗性 / ZM-B708 / ヒトがん幹細胞阻害薬 Less
  • Research Projects

    (2 results)
  • Research Products

    (6 results)
  • Co-Researchers

    (2 People)
  •  Systems pharmacology for discovering novel genes related to hypertrophic cardiomyopathy

    • Principal Investigator
      Nishimura Yuhei
    • Project Period (FY)
      2016 – 2018
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      General pharmacology
    • Research Institution
      Mie University
  •  in vivo Mechanisms of Novel Selective Fluorescent Leukemia Stem Cell Inhibitor

    • Principal Investigator
      Tanaka Toshio
    • Project Period (FY)
      2015
    • Research Category
      Grant-in-Aid for Challenging Exploratory Research
    • Research Field
      General pharmacology
    • Research Institution
      Mie University

All 2016 2015

All Journal Article

  • [Journal Article] Downregulation of GSTK1 Is a Common Mechanism Underlying Hypertrophic Cardiomyopathy2016

    • Author(s)
      Shota Sasagawa, Yuhei Nishimura, Shiko Okabe, Soichiro Murakami, Yoshifumi Ashikawa, Mizuki Yuge, Koki Kawaguchi, Reiko Kawase, Ryuji Okamoto, Masaaki Ito and Toshio Tanaka
    • Journal Title

      Frontiers in pharmacology

      Volume: 7 Pages: 162-162

    • DOI

      10.3389/fphar.2016.00162

    • Peer Reviewed / Acknowledgement Compliant / Open Access
    • Data Source
      KAKENHI-PROJECT-16K08547
  • [Journal Article] In Vivo Detection of Mitochondrial Dysfunction Induced by Clinical Drugs and Disease-Associated Genes Using a Novel Dye ZMJ214 in Zebrafish.2016

    • Author(s)
      Sasagawa S, Nishimura Y, Koiwa J, Nomoto T, Shintou T, Murakami S, Yuge M, Kawaguchi K, Kawase R, Miyazaki T, Tanaka T.
    • Journal Title

      ACS Chem Biol.

      Volume: 11 Issue: 2 Pages: 381-388

    • DOI

      10.1021/acschembio.5b00751

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-15K15051
  • [Journal Article] DNA Damage Response Is Involved in the Developmental Toxicity of Mebendazole in Zebrafish Retina2016

    • Author(s)
      Shota Sasagawa, Yuhei Nishimura, Tetsuo Kon, Yukiko Yamanaka, Soichiro Murakami, Yoshifumi Ashikawa, Mizuki Yuge, Shiko Okabe, Koki Kawaguchi, Reiko Kawase and Toshio Tanaka
    • Journal Title

      Front. Pharmacol.

      Volume: 7

    • DOI

      10.3389/fphar.2016.00057

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-15K15051
  • [Journal Article] Using zebrafish in systems toxicology for developmental toxicity testing.2016

    • Author(s)
      Nishimura Y, Inoue A, Sasagawa S, Koiwa J, Kawaguchi K, Kawase R, Maruyama T, Kim S, Tanaka T.
    • Journal Title

      Congenit Anom (Kyoto).

      Volume: 56 Issue: 1 Pages: 18-27

    • DOI

      10.1111/cga.12142

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-15K15051
  • [Journal Article] Pharmacological profiling of zebrafish behavior using chemical and genetic classification of sleep-wake modifiers2015

    • Author(s)
      Nishimura Y, Okabe S, Sasagawa S, Murakami S, Ashikawa Y, Yuge M, Kawaguchi K, Kawase R,Tanaka T.
    • Journal Title

      Front Pharmacol.

      Volume: 6

    • DOI

      10.3389/fphar.2015.00257

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-15K15051
  • [Journal Article] Systems pharmacology of adiposity reveals inhibition of EP300 as a common therapeutic mechanism of caloric restriction and resveratrol for obesity.2015

    • Author(s)
      Nishimura Y, Sasagawa S, Ariyoshi M, Ichikawa S, Shimada Y, Kawaguchi K, Kawase R, Yamamoto R, Uehara T, Yanai T, Takata R, Tanaka T.
    • Journal Title

      Front Pharmacol.

      Volume: 6

    • DOI

      10.3389/fphar.2015.00199

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-15K15051
  • 1.  Tanaka Toshio (00135443)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 6 results
  • 2.  Nishimura Yuhei (30303720)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 6 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi